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Background
Both asthma and COPD affect mental health due to
their impact on activities, sleep and social life of patients
and can be resulted in anxiety and depression. The
objective of the study was to determine and compare
the prevalence of anxiety and depression in asthma and
COPD patients.
Methods
Subjects without known psychiatric diseases were conse-
cutively recruited from pulmonary and allergy out-
patient clinics at the third level hospitals. Diagnosis of
asthma and COPD was based on GINA and GOLD
guideline, respectively. Depression and anxiety symp-
toms were evaluated using Beck Depression Inventory
(BDI) and Beck Anxiety Inventory (BAI).
Results
Study group consisted of 53 patients-30 with asthma
and 22 with COPD. All patients had moderate-to severe
diseases. COPD group was older, had more smoking
history and higher number of hospitalization than those
in asthmatics. Atopy rate and education level was higher
in asthmatics than those in COPD group. The mean
BDI and BAI scores were 17.96±12.39 and 20.57± 12.67
in the whole group. Both group had similar degree of
anxiety (21.23±11.7 vs. 19.7±14), whereas BDI score was
significantly higher in COPD group than that in asth-
matics (15.63±13.6 vs. 21±10.1) (p=.02). Age, gender,
smoking history, education level, atopy status, number
of emergency room admission was not correlated with
scores of BDI and BAI for both group. The only effec-
tive parameter on BDI score in COPD patients was hav-
ing comorbidities
Conclusions
Both asthmatics and COPD patients regardless of their
sociodemographic and clinical features have similar
degree of anxiety. In addition COPD patients are more
depressive than asthmatics. The study indicates that psy-
chiatric evaluation should be a part of tailoring therapy
in chronic respiratory diseases.
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